|
|
||||||||
-induced NF-
B
activation and apoptosis in hepatocytes
Department of Medicine, Biochemistry, and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599
Nuclear
factor-
B (NF-
B) prevents hepatocytes from undergoing
apoptosis during development and liver regeneration. Mice with inactivated glycogen synthase kinase (GSK)-3
die from hepatocyte apoptosis during development due to a defect in NF-
B
activation (Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, and Woodgett
JR. Nature 406: 86-90, 2000). In this study, we
determined the role of GSK-3 in TNF-
-induced NF-
B activation and
cell death in primary hepatocytes. LiCl, an established inhibitor of
GSK-3, sensitized primary rat hepatocytes toward TNF-
-mediated
apoptosis resulting in 90% cell death after 24 h. This
was accompanied by increased caspase 8-like and 3-like activities,
nuclear fragmentation and DNA laddering. LiCl treatment had no effect
on I
B-
degradation, I
B kinase (IKK) activity, NF-
B binding
activity, and p65 nuclear import and export, but decreased
transcription of the NF-
B-dependent inducible nitric oxide synthase
gene and a NF-
B-driven reporter gene. The p65 sequence revealed four
potential GSK-3 phosphorylation sites within its COOH-terminal
transactivation domains and recombinant GSK-3
phosphorylated
glutathione S-transferase (GST)-p65(354-551), but not
GST-p65(1-305) in vitro. These results indicate that GSK-3 protects hepatocytes from TNF-
-induced apoptosis through p65 phosphorylation and upregulation of NF-
B transactivation.
p65 phosphorylation; p65 transactivation; I
B kinase; tumor
necrosis factor-
; nuclear factor-
B
This article has been cited by other articles:
![]() |
S. Kotliarova, S. Pastorino, L. C. Kovell, Y. Kotliarov, H. Song, W. Zhang, R. Bailey, D. Maric, J. C. Zenklusen, J. Lee, et al. Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-{kappa}B, and Glucose Regulation Cancer Res., August 15, 2008; 68(16): 6643 - 6651. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Sasaki, C. F. Slemenda, P. Ghosh, T. J. Barberi, and D. L. Longo Traf1 Induction and Protection from Tumor Necrosis Factor by Nuclear Factor-{kappa}B p65 Is Independent of Serine 536 Phosphorylation Cancer Res., December 1, 2007; 67(23): 11218 - 11225. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Bao, S. Lim, W. Liao, Y. Lin, C. Thiemermann, B. P. Leung, and W. S. F. Wong Glycogen Synthase Kinase-3beta Inhibition Attenuates Asthma in Mice Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 431 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Lin, C.-L. Chen, C.-W. Chiang, M.-S. Jan, W.-C. Huang, and Y.-S. Lin GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis J. Cell Sci., August 15, 2007; 120(16): 2935 - 2943. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ougolkov, N. D. Bone, M. E. Fernandez-Zapico, N. E. Kay, and D. D. Billadeau Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor {kappa}B target genes and induction of apoptosis in chronic lymphocytic leukemia B cells Blood, July 15, 2007; 110(2): 735 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ougolkov, M. E. Fernandez-Zapico, V. N. Bilim, T. C. Smyrk, S. T. Chari, and D. D. Billadeau Aberrant Nuclear Accumulation of Glycogen Synthase Kinase-3{beta} in Human Pancreatic Cancer: Association with Kinase Activity and Tumor Dedifferentiation Clin. Cancer Res., September 1, 2006; 12(17): 5074 - 5081. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Schwabe and D. A. Brenner Mechanisms of Liver Injury. I. TNF-{alpha}-induced liver injury: role of IKK, JNK, and ROS pathways Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G583 - G589. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tan, L. Geng, E. M. Yazlovitskaya, and D. E. Hallahan Protein Kinase B/Akt-Dependent Phosphorylation of Glycogen Synthase Kinase-3{beta} in Irradiated Vascular Endothelium Cancer Res., February 15, 2006; 66(4): 2320 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Steinbrecher, W. Wilson III, P. C. Cogswell, and A. S. Baldwin Glycogen Synthase Kinase 3{beta} Functions To Specify Gene-Specific, NF-{kappa}B-Dependent Transcription Mol. Cell. Biol., October 1, 2005; 25(19): 8444 - 8455. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ougolkov, M. E. Fernandez-Zapico, D. N. Savoy, R. A. Urrutia, and D. D. Billadeau Glycogen Synthase Kinase-3{beta} Participates in Nuclear Factor {kappa}B-Mediated Gene Transcription and Cell Survival in Pancreatic Cancer Cells Cancer Res., March 15, 2005; 65(6): 2076 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Kuemmerle Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3{beta} activity Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G101 - G110. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Hayden and S. Ghosh Signaling to NF-{kappa}B Genes & Dev., September 15, 2004; 18(18): 2195 - 2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rao, C.-M. Hao, and M. D. Breyer Hypertonic Stress Activates Glycogen Synthase Kinase 3{beta}-mediated Apoptosis of Renal Medullary Interstitial Cells, Suppressing an NF{kappa}B-driven Cyclooxygenase-2-dependent Survival Pathway J. Biol. Chem., February 6, 2004; 279(6): 3949 - 3955. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liao, L. Zhang, J. B. Thrasher, J. Du, and B. Li Glycogen synthase kinase-3{beta} suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer Mol. Cancer Ther., November 1, 2003; 2(11): 1215 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Doble and J. R. Woodgett GSK-3: tricks of the trade for a multi-tasking kinase J. Cell Sci., April 1, 2003; 116(7): 1175 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Loberg, E. Vesely, and F. C. Brosius III Enhanced Glycogen Synthase Kinase-3beta Activity Mediates Hypoxia-induced Apoptosis of Vascular Smooth Muscle Cells and Is Prevented by Glucose Transport and Metabolism J. Biol. Chem., October 25, 2002; 277(44): 41667 - 41673. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |